+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Topical Drugs Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), End-use (Burn Centers, Home Care Settings, Hospitals & Clinics) - Forecast 2024-2030- Product Image
Global Topical Drugs Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), End-use (Burn Centers, Home Care Settings, Hospitals & Clinics) - Forecast 2024-2030- Product Image
Sale

Global Topical Drugs Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), End-use (Burn Centers, Home Care Settings, Hospitals & Clinics) - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666377
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Drugs Market size was estimated at USD 15.44 billion in 2023, USD 16.86 billion in 2024, and is expected to grow at a CAGR of 9.64% to reach USD 29.43 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Topical Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Topical Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Topical Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A, Bausch Health Companies Inc., Bayer AG, Cigna Health and Life Insurance Company, Concert Pharmaceuticals, Eli Lilly and Company, GlaxoSmithkline PLC, Hisamitsu Pharmaceuticals Co. Inc., Johnson & Johnson Services, Inc., LEO Pharma A/S, Lupin Limited, Mayne Pharma Group Limited, Mylan N.V., and Tergus Pharma.

Market Segmentation & Coverage

This research report categorizes the Topical Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Liquid Formulations
      • Solutions
      • Suspensions
    • Semi-Solid Formulations
      • Creams
      • Gel
      • Lotions
      • Ointments
      • Pastes
    • Solid Formulations
      • Powders
      • Suppositories
    • Transdermal Products
      • Transdermal Patches
      • Transdermal Semi-Solids
  • End-use
    • Burn Centers
    • Home Care Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Topical Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Topical Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Topical Drugs Market?
  4. What is the market share of the leading vendors in the Topical Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Topical Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Topical Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of skin disorders, and diabetes
5.1.1.2. Increasing demand for self-administered drugs and steroid-free topical medication
5.1.1.3. Favorable government approvals for topical drugs
5.1.2. Restraints
5.1.2.1. Irritations and allergies associated with topical treatments
5.1.3. Opportunities
5.1.3.1. Innovation in topical drug formulations
5.1.3.2. Advancements in drug delivery systems
5.1.4. Challenges
5.1.4.1. Complex formulations of topical drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Topical Drugs Market, by Product
6.1. Introduction
6.2. Liquid Formulations
6.3.1. Solutions
6.3.2. Suspensions
6.3. Semi-Solid Formulations
6.4.1. Creams
6.4.2. Gel
6.4.3. Lotions
6.4.4. Ointments
6.4.5. Pastes
6.4. Solid Formulations
6.5.1. Powders
6.5.2. Suppositories
6.5. Transdermal Products
6.6.1. Transdermal Patches
6.6.2. Transdermal Semi-Solids
7. Topical Drugs Market, by End-use
7.1. Introduction
7.2. Burn Centers
7.3. Home Care Settings
7.4. Hospitals & Clinics
8. Americas Topical Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Topical Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Topical Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Almirall, S.A
12.1.3. Bausch Health Companies Inc.
12.1.4. Bayer AG
12.1.5. Cigna Health and Life Insurance Company
12.1.6. Concert Pharmaceuticals
12.1.7. Eli Lilly and Company
12.1.8. GlaxoSmithkline PLC
12.1.9. Hisamitsu Pharmaceuticals Co. Inc.
12.1.10. Johnson & Johnson Services, Inc.
12.1.11. LEO Pharma A/S
12.1.12. Lupin Limited
12.1.13. Mayne Pharma Group Limited
12.1.14. Mylan N.V.
12.1.15. Tergus Pharma
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. TOPICAL DRUGS MARKET RESEARCH PROCESS
FIGURE 2. TOPICAL DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TOPICAL DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. TOPICAL DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. TOPICAL DRUGS MARKET DYNAMICS
FIGURE 7. TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. TOPICAL DRUGS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 10. TOPICAL DRUGS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. TOPICAL DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 8. TOPICAL DRUGS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TOPICAL DRUGS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 12. TOPICAL DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TOPICAL DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TOPICAL DRUGS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TOPICAL DRUGS MARKET SIZE, BY PASTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 19. TOPICAL DRUGS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. TOPICAL DRUGS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 23. TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 26. TOPICAL DRUGS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. TOPICAL DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. TOPICAL DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. CANADA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CANADA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 50. CANADA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 51. CANADA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 52. CANADA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 53. CANADA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. MEXICO TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 56. MEXICO TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 59. MEXICO TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. CHINA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. CHINA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 82. CHINA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 83. CHINA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 84. CHINA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 85. CHINA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. INDIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. INDIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 88. INDIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 89. INDIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 90. INDIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 91. INDIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. JAPAN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. JAPAN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 100. JAPAN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 101. JAPAN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 102. JAPAN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 103. JAPAN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. THAILAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. THAILAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 136. THAILAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 137. THAILAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 138. THAILAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 139. THAILAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. DENMARK TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 157. DENMARK TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 158. DENMARK TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 159. EGYPT TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. EGYPT TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 161. EGYPT TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 163. EGYPT TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 164. EGYPT TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. FINLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. FINLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 167. FINLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 169. FINLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. FRANCE TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 175. FRANCE TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 176. FRANCE TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. GERMANY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 179. GERMANY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. ITALY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. ITALY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 191. ITALY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 192. ITALY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 193. ITALY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 194. ITALY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 207. NORWAY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. NORWAY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 209. NORWAY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 211. NORWAY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 213. POLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. POLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 215. POLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 216. POLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 217. POLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 218. POLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 219. QATAR TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. QATAR TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 221. QATAR TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 222. QATAR TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 223. QATAR TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 224. QATAR TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 243. SPAIN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. SPAIN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 245. SPAIN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 248. SPAIN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 261. TURKEY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. TURKEY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 263. TURKEY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 264. TURKEY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 265. TURKEY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 266. TURKEY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 279. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 280. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 281. TOPICAL DRUGS MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Almirall, S.A
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cigna Health and Life Insurance Company
  • Concert Pharmaceuticals
  • Eli Lilly and Company
  • GlaxoSmithkline PLC
  • Hisamitsu Pharmaceuticals Co. Inc.
  • Johnson & Johnson Services, Inc.
  • LEO Pharma A/S
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Mylan N.V.
  • Tergus Pharma

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 16.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 29.43 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Topical Drug Delivery Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), Rout to Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery), End-User - Forecast 2024-2030 - Product Image

Global Topical Drug Delivery Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), Rout to Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery), End-User - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Topical Drug Delivery Global Market Report 2024 - Product Image

Topical Drug Delivery Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Topical Drug Delivery - Global Strategic Business Report - Product Image

Topical Drug Delivery - Global Strategic Business Report

  • Report
  • 94 Pages
  • Global
From
Global Topical Drug Delivery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Topical Drug Delivery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 172 Pages
  • Global
From
Otc Topical Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Otc Topical Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 110 Pages
  • Global
From

About the Ointment Market

The Ointment market within the context of Over the Counter (OTC) Drugs is a large and diverse industry. Ointments are topical medications used to treat a variety of skin conditions, such as eczema, psoriasis, and acne. Ointments are typically composed of a combination of oils, waxes, and other ingredients, and are applied directly to the skin. Ointments are available in a variety of forms, including creams, lotions, and gels. The Ointment market is highly competitive, with a wide range of products available from both large and small companies. Many of the leading Ointment manufacturers are multinational corporations, with products sold in countries around the world. In addition, there are a number of smaller, independent companies that specialize in Ointment products. Some of the leading companies in the Ointment market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Bayer. These companies produce a wide range of Ointment products, including creams, lotions, and gels. Other companies in the Ointment market include CVS, Walgreens, and Rite Aid. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.